Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: An analysis of three-year surveillance data-Reference-Cited by-同舟云学术

Effectiveness of post-exposure prophylaxis during varicella outbreaks among primary and middle school students in Shanghai: An analysis of three-year surveillance data

Published:2018-09 Issue:38 Volume:36 Page:5754-5759
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Cao Zhijuan,Chen Daoyong,Yang Yanji,Zhang Donglan

Funder

Hongkou District Health and Family Planning Commission, Shanghai, China

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference34 articles.

1. WHO: Weekly epidemiological record;World Health Organization (WHO),2014

2. Live vaccine used to prevent the spread of varicella in children in hospital;Takahashi;The Lancet,1974

3. Varicella disease after introduction of varicella vaccine in the United States 1995–2000;Seward;J Am Med Assoc,2002

4. Varicella vaccine uptake in Shandong province China;Xu;Hum Vaccines Immunother,2012

5. The varicella vaccination pattern among children under 5 years old in selected areas in China;Yue;Oncotarget,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Varicella Vaccination for 1–4-Year-Olds in Shanghai, China;American Journal of Preventive Medicine;2024-08

2. Effectiveness of varicella vaccination during an outbreak in a large one-dose-vaccinated population in Shanghai;Human Vaccines & Immunotherapeutics;2022-12-12

3. Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis;Human Vaccines & Immunotherapeutics;2021-12-10

4. Vaccines for measles, mumps, rubella, and varicella in children;Cochrane Database of Systematic Reviews;2021-11-22

5. Effectiveness of one-dose versus two-dose varicella vaccine in children in Qingdao, China: a matched case-control study;Human Vaccines & Immunotherapeutics;2021-10-08